Speakers

Special Session | Posters | Delegates

Andrew V. Schally, University of Miami, USA
Title: Hypothalamic Hormones: Hypothalamic hormones: from neuro-endocrinology to therapy of cancer and other diseases
David A. Boothman, UT Southwestern Medical Center, USA
Title: Use of NQO1 bioactivatable drugs to make PARP inhibitor tumor-selective
Mousa Shaker, Albany College of Pharmacy and Health Sciences, USA
Title: Nano-Targeting of cancer and its microenvironment
Danny R. Welch, The Kansas University Medical Center, USA
Title: Mitochondrial polymorphisms regulate metastatic efficiency
John T Isaacs, The Johns Hopkins School of Medicine, USA
Title: Conversion of Androgen Receptor Signaling from a Growth Suppressor in Normal Prostate Epithelial Cells to an Oncogene in Prostate Cancer Cells Involves a Gain of Function in c-Myc Expression and DNA Replication Licensing
Chau-Ting Yeh, Chang Gung Memorial Hospital, Taiwan
Title: Clinical implications of the GALNT14-rs9679162 genotype polymorphism – a therapeutic outcome predictor for multiple gastrointestinal cancers
Joyce M. Slingerland, University of Miami Miller School of Medicine, USA
Title: Estrogens and inflammation- new insights into the increased risk of ER+ post-menopausal breast cancer with obesity
Hiroshi Kobayashi , Chiba University, National university in Chiba, Japan
Title: Anti-cancer chemotherapeutics having high efficacy in acidified
Mukesh Verma, NIH/NCI, USA
Title: Epigenetic approaches in cancer risk assessment and etiology
Myron R. Szewczuk, Queen’s University, Kingston, Canada
Title: Smart active tumor targeting drug delivery systems
Indraneel Mittra, Tata Memorial Centre, India
Title: Biology of cell-free nucleic acids and their role in initiation and metastasis of cancer
Appu Rathinavelu, Rumbaugh Goodwin Institute for Cancer Research, USA
Title: MDM2 Oncogene: A new biomarker for metastatic cancers
Hildegard M. Schuller, The University of Tennessee, USA
Title: Targeting the neurotransmitter-driven regulation of cancer stem cells in cancer of the lungs and pancreas
Asher Chanan Khan , Mayo Clinic Cancer Center, USA
Title: TBA
Ramandeep Rattan, Women Health Services, Henry Ford Hospital, USA
Title: Role of AMPK in ovarian cancer: an immune perspective
Li Zhang, The University of Texas at Dallas, USA
Title: Heme and mitochondrial function in non-small cell lung cancer
Olivier Dormond, CHUV, Swizterland
Title: Acidity as a resistance mechanism to targeted therapies in cancer
Kenny Chitcholtan , University of Otago, New Zealand
Title: TBA
Erik Norberg, Karolinska Institute, Sweden
Title: PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor Prognosis
Jianchang (Jerry) Yang, Balor College of Medicine, USA
Title: SALL4 is an essential regulator in MLL-rearranged leukemogenesis
PK Epling-Burnette, Moffit Cancer Center, USA
Title: TBA
Mark Jackson, Case Comprehensive Cancer Center, USA
Title: Scanning the tumor microenvironment for targetable mediators of cancer stem cell plasticity.
Jingmei Jiang, Peking Union Medical College, China
Title: To determine whether smoking, in any form, is a risk factor in the development of cervical cancer (CC) among urban chinese women
LuZhe Sun, University of Texas Health Science Center, USA
Title: Role of aging-associated genes in regulating breast cancer metastasis
Wiseman Roque Gabriel Pinto, Goa Medical College , India
Title: Role of dietary broiler chicken and milk in the causation of breast cancer- A study conducted in Goa, India
Erwin Danil Yulian, University of Indonesia, Indonesia
Title: The role of simvastatin in inhibiting migration and proliferation of breast cancer cells through Rho/ROCK signaling pathway
Bessi Qorri, Queen's University, Canada
Title: Chemotherapy-sensitizing effects of aspirin, metformin, and oseltamivir phosphate in pancreatic cancer
Manpreet Sambi, Queen's University, Canada
Title: Therapeutic targeting human pancreatic cancer stem cells
S. K. Awasthi, University of Delhi, India
Title: Anticancer activities of newer tetraoxane analogs
Alka Agarwal, Banaras Hindu University, India
Title: 1,2,3 Triazole tethered chalcone and flavone hybrids as potential cytotoxic & antimicrobial agents
Thomas Griffith, University of Minnesota, USA
Title: TBA
Swei (Sunny) Hann, Guangzhou University of Chinese Medicine, China
Title: The enhancement of combination of berberine and metformin in inhibition of DNMT1 gene expression through interplay of SP1 and PDPK1 in lung cancer
Eric K. Lau, Moffitt Cancer Center, USA
Title: Roles of fucosylation in melanoma and breast cancer
Lynch Conor C, Moffit Cancer Center, USA
Title: New therapeutic approaches to tackling bone metastatic disease
Uwe Rix, Moffit Cancer Center, USA
Title: New insight into targeting the WEE1 signaling axis
Susann Brady Kalnay, Case Western Reserve University, USA
Title: Detection of tumors by PTPmu molecular imaging agents
Bramanandam Manavathi, University of Hyderabad, India
Title: Emerging role of HPIP signaling in cancer cell survival, EMT and metastasis under metabolic stress
Kim M. Hirshfield, Rutgers Cancer Institute of New Jersey, USA
Title: Genomic profiling reveals promising therapeutic targets in breast cancer
Terry W. Moody, NCI Center for Cancer Research, USA
Title: GPCR regulate RTK transactivation in NSCLC
Sujata Ghosh, Post Graduate Institute of Medical Education & Research, India
Title: Disease associated sialoglycoproteins of non-small cell lung cancer
Herman Mansur, Federal University of Minas Gerais, Brazil
Title: Evaluation of cytotoxicity of phosphoethanolamine drug toward human cancer cell lines
Natalia Issaeva, Yale University, USA & Lowy Cancer Research Centre, Australia
Title: Epigenetic therapy for HPV-associated cancer
Sabine Windhorst, Universitätsklinikum Hamburg-Eppendorf, Germany
Title: Cytoskeleton-associated proteins as targets for tumor therapy
Jeffrey Gu, University of Saskatchewan, Canada
Title: Understanding women’s choice of mastectomy versus breast conserving therapy in early-stage breast cancer
Chia-Hsin (Lori) Chan, The State University of New York at Stony Brook, USA
Title: E3 Ubiquitin ligases as drug targets in human cancer
Kenneth G. Hull, Baylor University, TX, USA
Title: Development of novel pateamine a derivatives as first-in-class translation initiation inhibitors targeting the vulnerabilities of cancer
Meenakshi Akulwar, NKP Salve Institute of Medical Sciences and Research Centre, India
Title: Comparative cytological techniques in the diagnosis of non-neoplastic and neoplastic bronchopulmonary lesions
Wael El-Rifai, Sylvester Comprehensive Cancer Center, University of Miami, USA
Title: Functional genomics in gastroesophageal cancer: can we target?
Karina Galoian, University of Miami, Miller School of Medicine, USA
Title: Neuropeptide prp-1 as a potent regulator of tumor suppressors and oncoproteins in human chondrosarcoma
Xin-Hai Pei, University of Miami Miller School of Medicine , USA
Title: Control of differentiation in lymphoma and breast cancer
Carlos Perez-Stable, University of Miami Miller School of Medicine, USA
Title: A New Strategy to Increase Proteotoxic Cell Death in Prostate Cancer
Haitao Wu, NIH/NCI, USA
Title: TBA
Marzenna Blonska, University of Miami Miller School of Medicine, USA
Title: The CBM signalosome: Pathogenetic role and therapeutic implications in cancer
M.N. VanSaun, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, USA
Title: Blocking mechanisms of obesity dependent pancreatic cancer progression
Jennifer J. Hu, University of Miami Miller School of Medicine, USA
Title: Inflammatory biomarker in predicting breast cancer radiotherapy-induced early adverse skin reactions
Pei Wang, The University of Texas Health Science Center at San Antonio, USA
Title: TBA
Tendulkar Ketki, University of Nebraska Medical Center, USA
Title: Renal toxicities in targeted therapies
Gary W. Reuther, H. Lee Moffitt Cancer Center and Research Institute, Inc., USA
Title: Enhancing the efficacy of JAK2 inhibitors for myeloid neoplasms
Krithika Kodumudi, H .Lee Moffitt Cancer Center, USA
Title: Restoration of anti-oncodriver Th1 responses in breast cancer
Posters
Joshua J. Kleinman, University of Miami Miller School of Medicine, USA
Title: Metabolomics in predicting radiotherapy-induced normal tissue-toxicities in breast cancer patients
Gavin Ajami, University of Miami School of Medicine, USA
Title: Inflammatory biomarker in radiotherapy-related pain
Saad Alobid, College of Pharmacy, Nova Southeastern University, USA
Title: CDK1 promotes angiogenesis via regulating HIF-1α activity in MDM2 overexpressed prostate cancer
Mohammad Algahtani, College of Pharmacy, Nova Southeastern University, USA
Title: F16 is a novel new candidate for brain tumors
Ali Alaseem, College of Pharmacy, Nova Southeastern University, USA
Title: MDM2 overexpressing cancer cell lines control MMPs activity
Khalid Alhazzani, College of Pharmacy, Nova Southeastern University, USA
Title: Evaluation of antitumor effects of a novel inhibitor of VEGFR-2 in a colorectal xenograft model
Gregory Watson, H. Lee Moffitt Cancer Center, USA
Title: RPS3 fucosylation in melanoma cell biology
E.L. Albuquerque, Universidade Federal do Rio Grande do Norte, Natal-RN, Brazil
Title: Check Point Inhibitor Technique to Treat Breast Cancer
U.L. Fulco, Universidade Federal do Rio Grande do Norte, Natal-RN, Brazil
Title: Quantum Biochemistry Approach to Investigate the Binding Energy Features of a Cilengitide RGD- Integrin Compound
Keerthi Thallapureddy, Nova Southeastern University, Florida
Title: Evaluation of Crosstalk between FAK and MDR1 in Platinum Resistant Ovarian Cancer Cells
Delegates

Biral Amin
Riverside Health System, USA

Scott Campbell
Brisbane Neurosurgery, Australia